Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading Up 0.4% – Here’s Why

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) shares were up 0.4% during mid-day trading on Friday . The stock traded as high as $10.65 and last traded at $10.65. Approximately 225,508 shares changed hands during trading, an increase of 586% from the average daily volume of 32,893 shares. The stock had previously closed at $10.61.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Oaktree Acquisition Corp. III Life Sciences in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.

Oaktree Acquisition Corp. III Life Sciences Price Performance

The company has a fifty day moving average price of $10.61 and a 200-day moving average price of $10.54.

Institutional Trading of Oaktree Acquisition Corp. III Life Sciences

Several hedge funds have recently modified their holdings of the company. Clear Street Group Inc. bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 3rd quarter valued at about $231,000. Clear Street LLC boosted its holdings in shares of Oaktree Acquisition Corp. III Life Sciences by 265.1% in the second quarter. Clear Street LLC now owns 22,000 shares of the company’s stock valued at $230,000 after purchasing an additional 15,975 shares during the period. Readystate Asset Management LP purchased a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 3rd quarter worth $262,000. Meteora Capital LLC purchased a new stake in Oaktree Acquisition Corp. III Life Sciences in the second quarter worth about $517,000. Finally, Radcliffe Capital Management L.P. purchased a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 2nd quarter worth approximately $856,000.

About Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.